Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;53(10):4540-1.
doi: 10.1128/AAC.00565-09. Epub 2009 Jul 27.

Efficacy of albaconazole against Candida albicans in a vaginitis model

Affiliations

Efficacy of albaconazole against Candida albicans in a vaginitis model

Gloria M González et al. Antimicrob Agents Chemother. 2009 Oct.

Abstract

The efficacy of albaconazole (ABC) was evaluated using a murine model of vaginal Candida albicans infection. Both ABC and fluconazole (FLC) were effective in reducing the fungal load from vaginas of infected mice; however, ABC demonstrated encouraging activities against an FLC-resistant strain, with trends toward superiority over FLC in some treatment groups.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Calderon, L., R. Williams, M. Martinez, K. V. Clemons, and D. A. Stevens. 2003. Genetic susceptibility to vaginal candidiasis. Med. Mycol. 41:143-147. - PubMed
    1. Capilla, J., M. Ortoneda, F. J. Pastor, and J. Guarro. 2001. In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi. Antimicrob. Agents Chemother. 45:2635-2637. - PMC - PubMed
    1. Fernández-Torres, B., A. J. Carrillo, E. Martín, A. del Palacio, M. K. Moore, A. Valverde, M. Serrano, and J. Guarro. 2001. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45:2524-2528. - PMC - PubMed
    1. Garau, M., M. Pereiro, and A. del Palacio. 2003. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob. Agents Chemother. 47:2342-2344. - PMC - PubMed
    1. González, G. M., E. Robledo, D. Saldívar, G. González, F. Bosques, and E. Garza. 2007. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. Med. Mycol. 45:221-224. - PubMed